Comparison Overview

Pfizer

VS

Teva Pharmaceuticals

Pfizer

New York, New York, 10017, US
Last Update: 2025-12-09

We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 102,145
Subsidiaries: 3
12-month incidents
0
Known data breaches
0
Attack type number
0

Teva Pharmaceuticals

124 Dvora hanevi'a, Tel-Aviv, undefined, 6944020, IL
Last Update: 2025-12-09
Between 800 and 849

At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to push the boundaries of science, discover life-changing treatments, and deliver quality medicines. If patients have a need, we’re already working to address it. Because here, we are all in for better health. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: [email protected] Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 29,653
Subsidiaries: 5
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/pfizer.jpeg
Pfizer
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/teva-pharmaceuticals.jpeg
Teva Pharmaceuticals
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Pfizer
100%
Compliance Rate
0/4 Standards Verified
Teva Pharmaceuticals
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Pfizer in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Teva Pharmaceuticals in 2025.

Incident History — Pfizer (X = Date, Y = Severity)

Pfizer cyber incidents detection timeline including parent company and subsidiaries

Incident History — Teva Pharmaceuticals (X = Date, Y = Severity)

Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/pfizer.jpeg
Pfizer
Incidents

No Incident

https://images.rankiteo.com/companyimages/teva-pharmaceuticals.jpeg
Teva Pharmaceuticals
Incidents

No Incident

FAQ

Pfizer company demonstrates a stronger AI Cybersecurity Score compared to Teva Pharmaceuticals company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Teva Pharmaceuticals company has disclosed a higher number of cyber incidents compared to Pfizer company.

In the current year, Teva Pharmaceuticals company and Pfizer company have not reported any cyber incidents.

Neither Teva Pharmaceuticals company nor Pfizer company has reported experiencing a ransomware attack publicly.

Neither Teva Pharmaceuticals company nor Pfizer company has reported experiencing a data breach publicly.

Neither Teva Pharmaceuticals company nor Pfizer company has reported experiencing targeted cyberattacks publicly.

Neither Pfizer company nor Teva Pharmaceuticals company has reported experiencing or disclosing vulnerabilities publicly.

Neither Pfizer nor Teva Pharmaceuticals holds any compliance certifications.

Neither company holds any compliance certifications.

Teva Pharmaceuticals company has more subsidiaries worldwide compared to Pfizer company.

Pfizer company employs more people globally than Teva Pharmaceuticals company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Pfizer nor Teva Pharmaceuticals holds SOC 2 Type 1 certification.

Neither Pfizer nor Teva Pharmaceuticals holds SOC 2 Type 2 certification.

Neither Pfizer nor Teva Pharmaceuticals holds ISO 27001 certification.

Neither Pfizer nor Teva Pharmaceuticals holds PCI DSS certification.

Neither Pfizer nor Teva Pharmaceuticals holds HIPAA certification.

Neither Pfizer nor Teva Pharmaceuticals holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description

Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.

Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description

The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N